Catalyst Wire Dossier Catalyst Wire Dossier

Liposomal irinotecan (Onivyde)

irinotecan liposome · Merrimack Pharmaceuticals / Ipsen
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Liposomal irinotecan (Onivyde), covering 2024-11-14 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors:A Prospective Exploratory Study [Phase 2]

See pricing